Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35977219.
- Also identified by DOI 10.1001/jamahealthforum.2022.1821 and PMC identifier 9270692.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study assesses buprenorphine coverage and prior authorization requirements in US commercial formulary data from 2017 to 2021.
Medical subject headings
- Buprenorphine
- Prior Authorization